QBT-002

N/A

Report date: 2022/05/19 14:42:26
NME

Base Information

Drug NameQBT-002
Drug Alias NameQBT002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis, SclerosingCholestasis, Intrahepatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQing Bile Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesQing Bile Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis, SclerosingCholestasis, Intrahepatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A